Redcare Pharmacy Balance Sheet Health

Financial Health criteria checks 5/6

Redcare Pharmacy has a total shareholder equity of €534.5M and total debt of €243.7M, which brings its debt-to-equity ratio to 45.6%. Its total assets and total liabilities are €1.0B and €484.4M respectively.

Key information

45.6%

Debt to equity ratio

€243.73m

Debt

Interest coverage ration/a
Cash€209.90m
Equity€534.55m
Total liabilities€484.40m
Total assets€1.02b

Recent financial health updates

Recent updates

Here's Why Redcare Pharmacy (ETR:RDC) Can Afford Some Debt

Nov 11
Here's Why Redcare Pharmacy (ETR:RDC) Can Afford Some Debt

Is There Now An Opportunity In Redcare Pharmacy NV (ETR:RDC)?

Apr 21
Is There Now An Opportunity In Redcare Pharmacy NV (ETR:RDC)?

Are Investors Undervaluing Redcare Pharmacy NV (ETR:RDC) By 26%?

Apr 07
Are Investors Undervaluing Redcare Pharmacy NV (ETR:RDC) By 26%?

Investors Interested In Redcare Pharmacy NV's (ETR:RDC) Revenues

Mar 25
Investors Interested In Redcare Pharmacy NV's (ETR:RDC) Revenues

Redcare Pharmacy (ETR:RDC) Is Carrying A Fair Bit Of Debt

Feb 13
Redcare Pharmacy (ETR:RDC) Is Carrying A Fair Bit Of Debt

Why Investors Shouldn't Be Surprised By Redcare Pharmacy NV's (ETR:RDC) P/S

Dec 24
Why Investors Shouldn't Be Surprised By Redcare Pharmacy NV's (ETR:RDC) P/S

Is There An Opportunity With Redcare Pharmacy NV's (ETR:RDC) 48% Undervaluation?

Dec 06
Is There An Opportunity With Redcare Pharmacy NV's (ETR:RDC) 48% Undervaluation?

Is Redcare Pharmacy (ETR:RDC) Using Too Much Debt?

Sep 07
Is Redcare Pharmacy (ETR:RDC) Using Too Much Debt?

Why Redcare Pharmacy NV (ETR:RDC) Could Be Worth Watching

Aug 02
Why Redcare Pharmacy NV (ETR:RDC) Could Be Worth Watching

Why We're Not Concerned About Redcare Pharmacy NV's (ETR:RDC) Share Price

Jul 17
Why We're Not Concerned About Redcare Pharmacy NV's (ETR:RDC) Share Price

Broker Revenue Forecasts For Shop Apotheke Europe N.V. (ETR:SAE) Are Surging Higher

May 28
Broker Revenue Forecasts For Shop Apotheke Europe N.V. (ETR:SAE) Are Surging Higher

Here's Why Shop Apotheke Europe (ETR:SAE) Can Afford Some Debt

May 11
Here's Why Shop Apotheke Europe (ETR:SAE) Can Afford Some Debt

We Think Shop Apotheke Europe (ETR:SAE) Has A Fair Chunk Of Debt

Jan 10
We Think Shop Apotheke Europe (ETR:SAE) Has A Fair Chunk Of Debt

Is Shop Apotheke Europe (ETR:SAE) Using Too Much Debt?

Sep 25
Is Shop Apotheke Europe (ETR:SAE) Using Too Much Debt?

Is Shop Apotheke Europe (ETR:SAE) Weighed On By Its Debt Load?

Jun 08
Is Shop Apotheke Europe (ETR:SAE) Weighed On By Its Debt Load?

Is Shop Apotheke Europe (ETR:SAE) Using Too Much Debt?

Feb 28
Is Shop Apotheke Europe (ETR:SAE) Using Too Much Debt?

Here's Why Shop Apotheke Europe (ETR:SAE) Has A Meaningful Debt Burden

Aug 01
Here's Why Shop Apotheke Europe (ETR:SAE) Has A Meaningful Debt Burden

Shop Apotheke Europe N.V.'s (ETR:SAE) About To Shift From Loss To Profit

May 11
Shop Apotheke Europe N.V.'s (ETR:SAE) About To Shift From Loss To Profit

Financial Position Analysis

Short Term Liabilities: RDC's short term assets (€516.1M) exceed its short term liabilities (€243.9M).

Long Term Liabilities: RDC's short term assets (€516.1M) exceed its long term liabilities (€240.5M).


Debt to Equity History and Analysis

Debt Level: RDC's net debt to equity ratio (6.3%) is considered satisfactory.

Reducing Debt: RDC's debt to equity ratio has reduced from 64% to 45.6% over the past 5 years.


Balance Sheet


Cash Runway Analysis

For companies that have on average been loss-making in the past, we assess whether they have at least 1 year of cash runway.

Stable Cash Runway: RDC has sufficient cash runway for more than 3 years based on its current free cash flow.

Forecast Cash Runway: Insufficient data to determine if RDC has enough cash runway if its free cash flow continues to grow or shrink based on historical rates.


Discover healthy companies

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2024/12/22 12:15
End of Day Share Price 2024/12/20 00:00
Earnings2024/09/30
Annual Earnings2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Redcare Pharmacy NV is covered by 26 analysts. 12 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Volker BosseBaader Helvea Equity Research
Gerhard SchwarzBaader Helvea Equity Research
Alvira RaoBarclays